Wachovia Downgrades Valeant Pharmaceuticals (VRX) to Underperform; Risk/Reward Unfavorable
VRX Hot Sheet
Rating Summary:6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Wachovia downgrades Valeant Pharmaceuticals (NYSE: VRX) to Underperform. Valuation Range: $15 to $17.
Wachovia analyst says, "Three factors for the downgrade: bolt on acquisition strategy is unsustainable, in our opinion, current valuation prices in potential reward for retigabine but not the potential risks, and shares are trading at a significant premium relative to peers...Lowering our 2009 EPS estimate to $1.16 from $1.26 (including amortization). The change reflects the addition of the 8.375% notes, partially offset by 2.5% interest earned on the cash received. We are lowering our 2010 EPS estimate to $1.13 from $1.29 for the same reasons."
To see more analyst ratings on VRX Click Here.
Valeant Pharmaceuticals International is a multi-national specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Wachovia analyst says, "Three factors for the downgrade: bolt on acquisition strategy is unsustainable, in our opinion, current valuation prices in potential reward for retigabine but not the potential risks, and shares are trading at a significant premium relative to peers...Lowering our 2009 EPS estimate to $1.16 from $1.26 (including amortization). The change reflects the addition of the 8.375% notes, partially offset by 2.5% interest earned on the cash received. We are lowering our 2010 EPS estimate to $1.13 from $1.29 for the same reasons."
To see more analyst ratings on VRX Click Here.
Valeant Pharmaceuticals International is a multi-national specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
You May Also Be Interested In
- Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
- Goldman Sachs Boosts Numbers on PVH Corp (PVH) After Q1 Beat
Create E-mail Alert Related Categories
DowngradesRelated Entities
WachoviaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
